🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is conducted in order to find out if repeated doses of the monocl...
Status
Completed
Location
Study Site
Start Date
2010-12
Trial ID
NCT01481493
This is a double-blind, placebo-controlled, dose escalation trial of DCR-PH...
Status
Completed
Location
Boston Children's Hospital
Start Date
2017-12-06
Trial ID
NCT03392896
The purpose of the study is to evaluate efficacy of riliprubart compared to...
Status
Recruiting
Location
Alabama Neurology Associates- Site Number : 8400019
Start Date
2024-08-21
Trial ID
NCT06290141
Treatments Being Tested
The purposes of this study are: * To evaluate tolerability of the Galcanez...
Status
Completed
Location
Covance
Start Date
2015-10-19
Trial ID
NCT02576951
Treatments Being Tested
This study is limited to conduct in China only. The primary objective is to...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2021-07-28
Trial ID
NCT05387070
Treatments Being Tested
A randomized, double-blind, placebo-controlled phase I clinical study evalu...
Status
Not Yet Recruiting
Location
Huashan Hospital
Start Date
2025-04
Trial ID
NCT06945445
The purpose of this study is to evaluate the tolerability of two different ...
Status
Terminated
Location
Covance
Start Date
2015-01
Trial ID
NCT02337387
Treatments Being Tested
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
Primary objective: To evaluate the efficacy of tralokinumab compared with ...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2017-06-12
Trial ID
NCT03160885
Treatments Being Tested
This is a prospective, multicenter, randomized, double-blinded, placebo-con...
Status
Completed
Location
Investigator site 77 - US0010086
Start Date
2020-12-01
Trial ID
NCT04598451
Treatments Being Tested